Skip to main content

Antineutrophil cytoplasmic antibodies (ANCA): current perspectives

  • Chapter
The Vasculitides

Abstract

The idiopathic systemic vasculitides constitute a group of disorders characterized by more or less widespread inflammation of vessel walls generally without an underlying cause or an associated condition. The idiopathic vasculitides are traditionally grouped according to the size of the vessels involved and the histopathology of the inflammatory process. Such a classification is shown in Table 4.1. A recent modification of this scheme based on a more strict application of histopathological criteria with respect to the size of the vessels involved [1], is given in Table 4.2. The definitions and classification of the vasculitides demonstrate that histopathological findings are essential for making a diagnosis of a distinct vasculitic disorder. In clinical practice, however, pathognomonic histopathological findings are hard to obtain in most patients suspected of vasculitis, even in cases where multiple biopsies have been performed [2]. For this and other reasons, classification criteria have been designed by the American College of Rheumatologists (ACR) that are mainly based on clinical signs and symptoms [3]. These criteria can be used for the classification of patients who have al.ready have been proved to have vasculitis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Jennette, J.C., Falk, R.J., Andrassy, K. et al. (1994) Nomenclature of systemic vasculitides. Proposal of an International Consensus Conference. Arthritis Rheum., 37, 187–92.

    Article  PubMed  CAS  Google Scholar 

  2. Cohen Tervaert, J.W., Limburg, P.C., Elema, J.D. et al. (1991) Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis. Am. J. Med., 91, 59–66.

    Article  Google Scholar 

  3. Leavitt, R.Y., Fauci, A.S., Bloch, D.A. et al. (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s Granulomatosis. Arthritis Rheum., 33, 1101–7.

    Article  PubMed  CAS  Google Scholar 

  4. Davies, D.J., Moran, J.E., Niall, J.F. and Ryan, G.B. (1982) Segmental necrotizing glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br. Med. J., 285, 606.

    Article  CAS  Google Scholar 

  5. Van der Woude, F.J., Rasmussen, N., Lobatto, S. et al. (1985) Autoantibodies to neutrophils and monocytes: a new tool for diagnosis and a marker of disease activity in Wegener’s Granulomatosis. Lancet, ii, 425–9.

    Article  Google Scholar 

  6. Wiik, A. (1989) Delineation for a standard procedure for indirect immunofluorescence detection of ANCA. APMIS, 97 (Suppl. 6), S12–S13.

    Google Scholar 

  7. Cohen Tervaert, J.W., van der Woude, F.J., Fauci, A.S. et al. (1989) Association between active Wegener’s Granulomatosis and anticytoplasmic antibodies. Arch. Intern. Med., 149, 2461–5.

    Article  Google Scholar 

  8. Kallenberg, C.G.M., Mulder, A.H.L. and Cohen Tervaert, J.W. (1992) Antineutrophil cytoplasmic antibodies: a still growing class of autoantibodies in inflammatory disorders. Am. J. Med., 93, 675–82.

    Article  PubMed  CAS  Google Scholar 

  9. Falk, R.J. and Jennette, J.C. (1988) Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N. Engl. J. Med., 318, 1651–7.

    Article  PubMed  CAS  Google Scholar 

  10. Peter, H.H., Metzger, D., Rump, A. and Röther, E. (1993) ANCA in diseases other than systemic vasculitis. Clin. Exp. Immunol., 91 (Suppl. 1), S12–S14.

    Google Scholar 

  11. Goldschmeding, F., Van der Schoot, C.E., Ten Bokkel Huinink, D. et al. (1989) Wegener’s Granulomatosis autoantibodies identify a novel diisopropylfluor-ophosphate-binding protein in the lysosomes of normal human neutrophils. J. Clin. Invest., 84, 1577–87.

    Article  PubMed  CAS  Google Scholar 

  12. Niles, J.L., McCluskey, R.T., Ahmad, M.F. and Arnaout, M.A. (1989) Wegener’s Granulomatosis autoantigen is a novel serine proteinase. Blood, 74, 1888–93.

    PubMed  CAS  Google Scholar 

  13. Lüdemann, J., Utecht, B. and Gross, W.I. (1990) Anti-neutrophil cytoplasm antibodies in Wegener’s Granulomatosis recognize an elastinolytic enzyme. J. Exp. Med., 171, 357–62.

    Article  PubMed  Google Scholar 

  14. Goldschmeding, R., Cohen Tervaert, J.W., van der Schoot, C.E. et al. (1989) ANCA, anti-myeloperoxidase, and anti-elastase: three members of a novel class of autoantibodies against myeloid lysosomal enzymes. APMIS, 97 (S6), 48–9.

    Google Scholar 

  15. Cohen Tervaert, J.W., Mulder, A.H.L., Stegeman, C.A. et al. (1993) The occurrence of autoantibodies to human leukocyte elastase in Wegener’s Granulomatosis and other inflammatory disorders. Ann. Rheum. Dis., 52, 115–20.

    Article  Google Scholar 

  16. Charles, L.A., Falk, R.J. and Jennette, J.C. (1989) Reactivity of anti-neutrophil cytoplasmic autoantibodies with HL-60 cells. Clin. Immunol. Immunopathol., 53, 243–53.

    Article  PubMed  CAS  Google Scholar 

  17. Mulder, A.H.L., Horst, G., van Leeuwen, M.A. et al. (1993) Anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis: characterization and clinical correlations. Arthritis Rheum., 36, 1054–60.

    Article  PubMed  CAS  Google Scholar 

  18. Coremans, E.M., Hagen, E.C., Daha, M.R. et al. (1992) Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum., 35, 1466–75.

    Article  PubMed  CAS  Google Scholar 

  19. Mulder, A.H.L., Broekroelofs, J., Horst, G. et al. (1994) Antineutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates. Clin. Exp. Immunol., 95, 490–7.

    Article  PubMed  CAS  Google Scholar 

  20. Coremans, I.E.M., Hagen, E.C., Daha, M.R. et al. (1993) Anti-lactoferrin antibodies in patients with Felty’s syndrome. Clin. Exp. Immunol., 93 (Suppl. 1), S33.

    Google Scholar 

  21. Lee, S.S., Lawton J.W.M. and Chan, C.E. (1992) Antilactoferrin antibody in systemic lupus erythematosus. Brit. J. Rheumatol., 31, 669–73.

    Article  CAS  Google Scholar 

  22. Peen, E., Aimer, S., Bodemar, G. et al. (1993) Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis and Crohn’s disease. Gut, 34, 56–62.

    Article  PubMed  CAS  Google Scholar 

  23. Sinico, R.A., Pozzi, C., Radice, A. et al. (1993) Clinical significance of anti-neutrophil cytoplasmic autoantibodies with specificity for lactoferrin in renal diseases. Am. J. Kidney Dis., 22, 253–60.

    PubMed  CAS  Google Scholar 

  24. Halbwachs-Mecarelli, L.H., Nusbaum, L.H., Reumaux, D. et al. (1992) Anti-neutrophil cytoplasmic antibodies (ANCA) directed against Cathepsin G in ulcerative colitis, Crohn’s disease and primary sclerosing cholangitis. Clin. Exp. Immunol., 90, 79–84.

    Article  PubMed  CAS  Google Scholar 

  25. Kaneko, K., Suzuki, Y., Yamashiro, Y. and Yabuta, S. (1993) Is p-ANCA in ulcerative colitis directed against β glucuronidase? Lancet, 341, 320.

    Article  PubMed  CAS  Google Scholar 

  26. Nölle, B., Specks, U., Lüdemann, J. et al. (1989) Anticytoplasmic antibodies: their immunodiagnostic value in Wegener’s Granulomatosis. Ann. Intern. Med., 111, 28–40.

    Article  PubMed  Google Scholar 

  27. Weber, M.F.A., Andrassy, K., Pullig, O. et al. (1992) Antineutrophil cytoplasmic antibodies and antiglomerular basement membrane antibodies in Goodpasture’s syndrome and in Wegener’s granulomatosis. J. Am. Soc. Nephrol., 2, 1227–34.

    PubMed  CAS  Google Scholar 

  28. Cohen Tervaert, J.W., Goldschmeding, R., Elema, J.D. et al. (1990) Association of autoantibodies to myeloperoxidase with different forms of vasculitis. Arthritis Rheum., 33, 1264–72.

    Article  Google Scholar 

  29. Kallenberg, C.G.M. and Cohen Tervaert, J.W. (1992) Anti-neutrophilic cytoplasmic antibodies: new tools in the diagnosis and follow-up of necrotizing glomerulonephritis, in International Yearbook of Nephrology (eds V.E. Andreucci and L.G. Fine), pp. 313–36.

    Google Scholar 

  30. Cohen Tervaert, J.W., Goldschmeding, R., Elema, J.D. et al. (1990) Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int., 37, 799–806.

    Article  Google Scholar 

  31. Savage, C.O.S., Winearls, C.G., Evans, D.J. et al. (1985) Microscopic polyarteritis: presentation, pathology and prognosis. Q. J. Med., 56, 467–83.

    PubMed  CAS  Google Scholar 

  32. Pudifin, D.J., Duursma, J., Gathiram, V. and Jackson, T.F.G.H. (1993) Serum from patients with invasive amoebiasis has anti-neutrophil cytoplasmic antibody activity. Clin. Exp. Immunol., 93 (Suppl. 1), S33.

    Google Scholar 

  33. Dolman, K.M., Gans, R.O.B., Vervaart, T.H.J., et al. (1993) Vasculitic disorders and anti-neutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet, 342, 651–2.

    Article  PubMed  CAS  Google Scholar 

  34. Egner, W. and Chapel, H.M. (1990) Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitides. Clin. Exp. Immunol., 82, 244–9.

    Article  PubMed  CAS  Google Scholar 

  35. Cohen Tervaert, J.W., Huitema, M.G., Hené, R.J. et al. (1990) Prevention of relapses in Wegener’s granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet, 336, 709–11.

    Article  Google Scholar 

  36. Kerr, G.R., Fleischer, T.H.A., Hallahan, C.W. et al. (1993) Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener’s granulomatosis. Arthritis Rheum., 36, 365–71.

    Article  PubMed  CAS  Google Scholar 

  37. Cohen Tervaert, J.W., Stegeman, C.A., Huitema, M.G. and Kallenberg, C.G.M. (1994) Comments on article by Kerr et al. Arthritis Rheum., 37, 596–7.

    Article  Google Scholar 

  38. Stegeman, C.A., Cohen Tervaert, J.W., Sluiter, W.J. et al. (1994) Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener’s Granulomatosis. Ann. Intern. Med., 120, 12–7.

    Article  PubMed  CAS  Google Scholar 

  39. Cohen Tervaert, J.W., Goldschmeding, R., Von dem Borne, A.E.G.K.R. and Kallenberg, C.G.M. (1991) Anti-myeloperoxidase antibodies in the Churg-Strauss syndrome. Thorax, 46, 70–1.

    Article  Google Scholar 

  40. Jayne, D.R.W., Marshall, P.D., Jones, S.J. and Lockwood, C.M. (1990) Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int., 37, 965–70.

    Article  PubMed  CAS  Google Scholar 

  41. Bosch, X., Mirapeix, E., Font, J. et al. (1991) Prognostic implication of antineutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease. Clin. Nephrol., 36, 107–13.

    PubMed  CAS  Google Scholar 

  42. Niles, J.L., Pan, G., Collins, A.B. et al. (1991) Antigen-specific radio-immu-noassay for anti-neutrophil cytoplasmic antibodies in the diagnosis of rapidly progressive glomerulonephritis. J. Am. Soc. Nephrol., 2, 27–36.

    PubMed  CAS  Google Scholar 

  43. Gueirard, P., Delpech, A., Gilbert, D. et al. (1991) Anti-myeloperoxidase antibodies: immunological characteristics and clinical associations. J. Autoimm., 4, 517–27.

    Article  CAS  Google Scholar 

  44. Gallichio, M.C. and Savige, J.A. (1991) Detection of anti-myeloperoxidase and anti-elastase antibodies in vasculitis and infections. Clin. Exp. Immunol., 84, 232–7.

    Article  Google Scholar 

  45. Nässberger, L., Sjöholm, A.G., Jonsson, H. et al. (1990) Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus. Clin. Exp. Immunol., 81, 380–3.

    Article  PubMed  Google Scholar 

  46. Mulder, A.H.L., Horst, G., Haagsma, E.B. et al. (1993) Prevalence and characterization of anti-neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology, 17, 411–17.

    Article  PubMed  CAS  Google Scholar 

  47. Kallenberg, C.G.M., Cohen Tervaert, J.W. and Limburg, P.C. (1991) ELISA for the detection of antibodies against neutrophil cytoplasm antigens, in Techniques in diagnostic pathology, Vol. 2 (eds G.R. Bullock, D. van Velzen, M.J. Warhol and P. Herbrink), Academic Press, London, pp. 43–60.

    Google Scholar 

  48. Cohen Tervaert, J.W. and Kallenberg, C.G.M. (1993) Neurologic manifestations of systemic vasculitides, in Neurologic aspects of rheumatic diseases. Rheumatic Disease Clinics of North America (ed. K.B. Elkon), Vol. 19, WB Saunders, Philadelphia, pp. 913–40.

    Google Scholar 

  49. Kallenberg, C.G.M., Brouwer, E., Weening, J.J. and Cohen Tervaert, J.W. (1994) Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int., 46, 1–15.

    Article  PubMed  CAS  Google Scholar 

  50. Falk, R.J., Terrell, R.S., Charles, L.A. and Jennette, J.C. (1990) Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc. Nat. Acad. Sci. USA, 87, 4115–9.

    Article  CAS  Google Scholar 

  51. Charles, L.A., Caldas, M.L.R., Falk, R.J. et al. (1991) Antibodies against granule proteins activate neutrophils in vitro. J. Leuk. Biol., 50, 539–46.

    CAS  Google Scholar 

  52. Mulder, A.H.L., Horst, G., Limburg, P.C. and Kallenberg, C.G.M. (1993) Activation of neutrophils by anti-neutrophil cytoplasmic antibodies is FcR-dependent. Clin. Exp. Immunol., 93 (Suppl. 1), S16.

    Google Scholar 

  53. Van de Wiel, A., Dolman, K.M., van der Meer-Gerritsen, C.H. et al. (1992) Interference of Wegener’s Granulomatosis autoantibodies with neutrophil proteinase 3 activity. Clin. Exp. Immunol., 90, 409–14.

    Article  PubMed  Google Scholar 

  54. Dolman, K.M., Stegeman, C.A., van de Wiel, B.A. et al. (1993) Relevance of classic anti-neutrophil cytoplasmic autoantibody (c-ANCA)-mediated inhibition of proteinase 3-α1-antitrypsin complexation to disease activity in Wegener’s Granulomatosis. Clin. Exp. Immunol., 93, 405–10.

    Article  PubMed  CAS  Google Scholar 

  55. Brouwer, E., Huitema, M.G., Klok, P.A. et al., (1993) Anti-myeloperoxidase associated proliferative glomerulonephritis: an animal model. J. Exp. Med., 177, 905–14.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Kallenberg, C.G.M. (1996). Antineutrophil cytoplasmic antibodies (ANCA): current perspectives. In: Ansell, B.M., Bacon, P.A., Lie, J.T., Yazici, H. (eds) The Vasculitides. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2889-4_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-2889-4_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-412-64140-4

  • Online ISBN: 978-1-4899-2889-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics